New Insights into Using Lipid Based Suspensions for ‘Brick Dust’ Molecules: Case Study of Nilotinib

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Niklas J. Koehl, René Holm, Martin Kuentz, Brendan T. Griffin

Journal title: Pharmaceutical Research

Journal number: 36/4

Journal publisher: Kluwer Academic/Plenum Publishers

Published year: 2019

DOI identifier: 10.1007/s11095-019-2590-y

ISSN: 0724-8741